Arcturus Therapeutics Holdings (ARCT) Earnings Date & Reports

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ARCT is expected to report earnings to fall 93.68% to -5 cents per share on November 11

Arcturus Therapeutics Holdings ARCT Stock Earnings Reports

Q3'26

Est.

$-0.06

Q1'26

Beat

by $0.17

Q4'25

Missed

by $5.31

Q3'25

Missed

by $6.02

Q2'25

Missed

by $3.55

The last earnings report on May 07 showed earnings per share of -94 cents, beating the estimate of -112 cents. With 268.91K shares outstanding, the current market capitalization sits at 418.53M.

View a ticker or compare two or three

ARCT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ARCT